1,698
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Stereotactic radiofrequency ablation of a variety of liver masses in children

, , , , , , , , , , , , , , , , , , , , , & ORCID Icon show all
Pages 1074-1081 | Received 13 May 2020, Accepted 31 Aug 2020, Published online: 20 Sep 2020

References

  • Emre S, Umman V, Rodriguez-Davalos M. Current concepts in pediatric liver tumors. Pediatr Transplant. 2012;16(6):549–563.
  • Schnater JM, Aronson DC, Plaschkes J, et al. Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International society of pediatric oncology liver tumor study group. Cancer. 2002;94(4):1111–1120.
  • von Schweinitz D. Management of liver tumors in childhood. Semin Pediatr Surg. 2006;15(1):17–24.
  • Lau WY, Lai EC. The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review. Ann Surg. 2009;249(1):20–25.
  • Kim YS, Lee WJ, Rhim H, et al. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion. AJR Am J Roentgenol. 2010;195(3):758–765.
  • Pompili M, Saviano A, de Matthaeis N, et al. Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma </=3 cm. Results of a multicenter Italian survey. J Hepatol. 2013;59(1):89–97.
  • Nishikawa H, Kimura T, Kita R, et al. Radiofrequency ablation for hepatocellular carcinoma. Int J Hyperthermia. 2013;29(6):558–568.
  • Karall D, Scholl-Burgi S, Widmann G, et al. Stereotactic radiofrequency ablation for liver tumors in inherited metabolic disorders. Cardiovasc Intervent Radiol. 2014;37(4):1027–1033.
  • Liu B, Zhou L, Huang G, et al. First experience of ultrasound-guided percutaneous ablation for recurrent hepatoblastoma after liver resection in children. Sci Rep. 2015;5:16805.
  • Widmann G, Schullian P, Haidu M, et al. Stereotactic radiofrequency ablation (SRFA) of liver lesions: technique effectiveness, safety, and interoperator performance. Cardiovasc Intervent Radiol. 2012;35(3):570–580.
  • Cucchetti A, Piscaglia F, Cescon M, et al. Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma. J Hepatol. 2013;59(2):300–307.
  • EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69:182–236.
  • Fontana RJ, Hamidullah H, Nghiem H, et al. Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: a safe and effective bridge to liver transplantation. Liver Transpl. 2002;8(12):1165–1174.
  • Laeseke PF, Sampson LA, Haemmerich D, et al. Multiple-electrode radiofrequency ablation creates confluent areas of necrosis: in vivo porcine liver results. Radiology. 2006;241(1):116–124.
  • Bale R, Widmann G, Stoffner DI. Stereotaxy: breaking the limits of current radiofrequency ablation techniques. Eur J Radiol. 2010;75(1):32–36.
  • Widmann G, Schullian P, Haidu M, et al. Targeting accuracy of CT-guided stereotaxy for radiofrequency ablation of liver tumours. Minim Invasive Ther Allied Technol. 2011;20(4):218–225.
  • Bachmann N, Crazzolara R, Bohne F, et al. Novel deletion in 11p15.5 imprinting center region 1 in a patient with Beckwith-Wiedemann syndrome provides insight into distal enhancer regulation and tumorigenesis. Pediatr Blood Cancer. 2017;64(3):e26241.
  • Bale R, Widmann G, Haidu M. Stereotactic radiofrequency ablation. Cardiovasc Intervent Radiol. 2011;34(4):852–856.
  • Bale R, Schullian P, Eberle G, et al. Stereotactic radiofrequency ablation of hepatocellular carcinoma - a histopathological study in explanted livers. Hepatology. 2019;70(3):840–850.
  • Theilen TM, Soerensen J, Bochennek K, et al. Crizotinib in ALK(+) inflammatory myofibroblastic tumors-current experience and future perspectives. Pediatr Blood Cancer. 2018;65(4):e26920.
  • Schullian P, Widmann G, Lang TB, et al. Accuracy and diagnostic yield of CT-guided stereotactic liver biopsy of primary and secondary liver tumors. Comput Aided Surg. 2011;16(4):181–187.
  • Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Annals of Surgery. 2004;240(2):205–213.
  • Waich S, Roscher A, Brunner-Krainz M, et al. Severe DGUOK deficiency in Austria: a six-patient series. J Pediatr Gastroenterol Nutr. 2018;68(1):e1–e6.
  • Yevich S, Calandri M, Gravel G, et al. Reiterative radiofrequency ablation in the management of pediatric patients with hepatoblastoma metastases to the lung, liver, or bone. Cardiovasc Intervent Radiol. 2019;42(1):41–47.
  • van Aalten SM, de Man RA, Ij JN, et al. Systematic review of haemorrhage and rupture of hepatocellular adenomas. Br J Surg. 2012;99(7):911–916.
  • Deneve JL, Pawlik TM, Cunningham S, et al. Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy. Ann Surg Oncol. 2009;16(3):640–648.
  • Dokmak S, Paradis V, Vilgrain V, et al. A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology. 2009;137(5):1698–1705.
  • Mironov O, Jaberi A, Beecroft R, et al. Retrospective single-arm cohort study of patients with hepatocellular adenomas treated with percutaneous thermal ablation. Cardiovasc Intervent Radiol. 2018;41(6):935–941.
  • van Rosmalen BV, Coelen RJS, Bieze M, et al. Systematic review of transarterial embolization for hepatocellular adenomas. Br J Surg. 2017;104(7):823–835.
  • Craig P. Echinococcus multilocularis. Curr Opin Infect Dis. 2003;16(5):437–444.
  • McManus DP, Zhang W, Li J, et al. Echinococcosis. Lancet. 2003;362(9392):1295–1304.
  • Kern P. Clinical features and treatment of alveolar echinococcosis. Curr Opin Infect Dis. 2010;23(5):505–512.
  • Ayifuhan A, Tuerganaili A, Jun C, et al. Surgical treatment for hepatic alveolar echinococcosis: report of 50 cases. Hepatogastroenterology. 2012;59(115):790–793.
  • Joliat GR, Melloul E, Petermann D, et al. Outcomes after liver resection for hepatic alveolar echinococcosis: a single-center cohort study. World J Surg. 2015;39(10):2529–2534.
  • Qu B, Guo L, Sheng G, et al. Management of advanced hepatic alveolar echinococcosis: report of 42 cases. Am J Trop Med Hyg. 2017;96(3):680–685.
  • Buttenschoen K, Carli Buttenschoen D, Gruener B, et al. Long-term experience on surgical treatment of alveolar echinococcosis. Langenbecks Arch Surg. 2009;394(4):689–698.
  • Vuitton DA, Azizi A, Richou C, et al. Current interventional strategy for the treatment of hepatic alveolar echinococcosis. Expert Rev anti Infect Ther. 2016;14(12):1179–1194.
  • Brunetti E, Kern P, Vuitton DA, et al. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop. 2010;114(1):1–16.
  • Bale R, Richter M, Dunser M, et al. Stereotactic radiofrequency ablation for breast cancer liver metastases. J Vasc Interv Radiol. 2018;29(2):262–267.
  • Bale R, Schullian P, Schmuth M, et al. Stereotactic radiofrequency ablation for metastatic melanoma to the liver. Cardiovasc Intervent Radiol. 2016;39(8):1128–1135.
  • Zwintscher NP, Azarow KS, Horton JD. Morbidity and mortality associated with liver resections for primary malignancies in children. Pediatr Surg Int. 2014;30(5):493–497.
  • Veenstra MA, Koffron AJ. Minimally-invasive liver resection in pediatric patients: initial experience and outcomes. HPB (Oxford). 2016;18(6):518–522.